RFA Alert: Two Translational Research Opportunities

Published by CTSI on April 7, 2015

CTSI has released RFAs for the following funding programs:

  • Supports health research projects that intend to develop a novel therapeutic compound, device, diagnostic, or IT product, and have the potential to be commercialized.
  • Open to University of Minnesota and/or Mayo Clinic researchers
  • Offers either up to $50K to assess feasibility or establish merit, or up to $200K to advance past feasibility toward commercialization (i.e., funding for research that would specifically support the formation of a start-up company or license agreement).

Mandatory letters of intent due May 1.

View the RFA | Program details

  • Supports the development of pediatric medical devices, with the ultimate goal of improving pediatric patient outcomes and quality of life through technology-driven medical solutions.
  • Open to University of Minnesota faculty, including affiliated faculty at the VA, HCMC, Regions Hospital, and the Children's Hospitals of Minnesota.
  • Offers each funded project a maximum of $50K for one year.

Mandatory letters of intent due May 1.

View RFA | Program details

About our blog

The Clinical and Translational Science Institute's blog features news, events, and opportunities, as well as stories about the researchers we support.

Contact CTSI's communications team to share your research-related news.

Find all CTSI blog posts